Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam

This publication has 5 references indexed in Scilit:

• Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam
  Neurology, 2001
• Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy
  Epilepsy Research, 2000
• A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
  Seizure, 2000
• Action myoclonus (lance‐adam syndrome) secondary to strangulation with dramatic response to alcohol
  Movement Disorders, 1991
• Antimyoclonic effects of alcohol in progressive myoclonus epilepsy
  Neurology, 1990